|Title:|| Pharmaceutical composition|
|Abstract:||Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.|
|Inventor(s):|| Ikeda; Hitoshi (Higashiosaka, JP), Sohda; Takashi (Takatsuki, JP), Odaka; Hiroyuki (Kobe, JP) |
|Assignee:|| Takeda Chemical Industries, Ltd. (Osaka, JP) |
|Filing Date:||Jun 19, 1996|
|Claims:||1. Method for treating diabetes in a mammal in need thereof, which comprises administering to such mammal a therapeutically effective amount of 5-[[4-[2-(methyl-2-pyridylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedion e in combination with an .alpha.-glucosidase inhibitor. |
2. Method according to claim 1, wherein .alpha.-glucosidase inhibitor is selected from the group consisting of acarbose, voglibose and miglitol.
3. Method according to claim 1, wherein the .alpha.-glucosidase inhibitor is voglibose.